Broad Street Alerts

Broad Street Alerts Small Cap Stock Alerts, Research and News.

See our recent reports by joining our private Facebook trading group here - https://www.facebook.com/groups/BroadStreet.Breakout Seeking value and high growth small to mid-cap companies on the NASDAQ and NYSE exchange every day for our group of traders.

Swing / Breakout Watch for Tomorrow 09/30/2024 - https://mailchi.mp/broadstreetalerts/svre-swing-alert-4956215?e=(NASDAQ...
09/30/2024

Swing / Breakout Watch for Tomorrow 09/30/2024 - https://mailchi.mp/broadstreetalerts/svre-swing-alert-4956215?e=

(NASDAQ: $RELI) Pending accretive acquisition. Expected to add $28m in revenues. To close in Q4 2024.

September 09, 2024 - Reliance Global Group Announces Enhanced Terms for Pending Spetner Acquisition Full Article

Float 1.16m
Current $2.19
RSI 29

(NASDAQ: SVRE) est. 13m float, at $0.15/share, oversold RSI 32, strategic partnership with Volvo. Full analysis here >>>...
09/26/2024

(NASDAQ: SVRE) est. 13m float, at $0.15/share, oversold RSI 32, strategic partnership with Volvo. Full analysis here >>>https://broadstreetalerts.com/wp-content/uploads/2024/09/BSA-SVRE-SWING-ALERT.pdf

08/19/2024

Swing trade analysis. Watching for a break over $0.60/share (NASDAQ: AREB) >>> https://mailchi.mp/broadstreetalerts/areb-swing-alert?e=

American Rebel Holdings Inc (NASDAQ: AREB) Swing Alert with Momentum About American Rebel Holdings, Inc. American Rebel Holdings, Inc. (NASDAQ: AREB) has operated primarily as a designer, manufacturer and marketer of branded safes and personal security and self-defense products and has recently tran...

$SERV news out - Outlines Which Sectors and Companies Stand to Benefit Most from the AI Revolution Highlighting Serve Ro...
07/23/2024

$SERV news out - Outlines Which Sectors and Companies Stand to Benefit Most from the AI Revolution Highlighting Serve Robotics https://newsdirect.com/news/bestgrowthstocks-com-outlines-which-sectors-and-companies-stand-to-benefit-most-from-the-ai-revolution-highlighting-serve-robotics-580553482

Related or mentioned in this article/video: $SOUN $NVDA $RXRX $MSFT $AAPL $GOOG $BBAI $MITK

Video: https://youtu.be/kkau2fryvjc

Comprehensive analysis of the next beneficiaries of the AI revolution, which ones stand to benefit first, and stocks under $15/share to watch within each sec...

The Next Beneficiaries of the AI RevolutionAI Stocks to Buy Under $15/Share, Best AI Stocks.  Analysis of the next benef...
07/22/2024

The Next Beneficiaries of the AI Revolution
AI Stocks to Buy Under $15/Share, Best AI Stocks.

Analysis of the next beneficiaries of the AI revolution, which stands to benefit first, and stocks to watch within each sector: https://bestgrowthstocks.com/access-the-next-beneficiaries-of-the-ai-revolution/

See video here: https://youtu.be/kkau2fryvjc

Comprehensive analysis of the next beneficiaries of the AI revolution, which ones stand to benefit first, and stocks under $15/share to watch within each sec...

Hello everyone and welcome to our new members.Nortech Systems Inc. (NASDAQ: NSYS) Based in MinnesotaAnalysis and disclos...
06/18/2024

Hello everyone and welcome to our new members.

Nortech Systems Inc. (NASDAQ: NSYS) Based in Minnesota

Analysis and disclosures: https://mailchi.mp/broadstreetalerts/new-breakout-alert-06-06-95882?e=[UNIQID]

About Nortech Systems Incorporated

Nortech Systems is a leading provider of design and manufacturing solutions for complex electromedical devices, electromechanical systems, assemblies, and components. Nortech primarily serves the medical, aerospace & defense, and industrial markets. Its design services span concept development to commercial design, and include medical device, software, electrical, mechanical, and biomedical engineering. Its manufacturing and supply chain capabilities are vertically integrated around wire/cable/interconnect assemblies, printed circuit board assemblies, as well as system-level assembly, integration, and final test. Headquartered in Maple Grove, Minn., Nortech currently has seven manufacturing locations and design centers across the U.S., Latin America, and Asia. Nortech Systems is traded on the NASDAQ Stock Market under the symbol NSYS. Nortech's website is www.nortechsys.com.

Tailwinds:
Stock Buyback and New Board Member from 3M Just Announced

Float & Outstanding Shares: 1.16M / 2.76M
Annual Revenue: $138 million
Net Income: $6.96 million
Price-to-Earnings (P/E) Ratio: 5.43

Certification and Market Expansion
In October 2023, Nortech Systems was certified to produce Class II medical devices for the Asian market. This certification marks a significant milestone in the company’s expansion and compliance capabilities.

Fiber Optic Capabilities
The launch of the Expanded Beam Xtreme technology has positioned Nortech at the forefront of advanced manufacturing solutions.

Outlook
Nortech Systems appears ready for a bounce from oversold conditions. Its current P/E ratio is very low compared to peers, indicating potential undervaluation.

Price to Earnings

Price-to-Earnings (P/E) Ratios
As of June 2024, the average P/E ratios for the various industries Nortech Systems is involved in are as follows:
Medical Device Industry: 31.24 (Source: FullRatio) (as of June 2024)
U.S. Aerospace and Defense Industry: 33.2, higher than its 3-year average of 26.7 (as of June 2024)
Global Industrials: 18.35 (as of June 13, 2024)

The P/E ratio is calculated using the formula:

​Nortech Systems Inc. (NASDAQ: NSYS)
Nortech Systems, a company with profitability in the medical device, aerospace, and industrial sectors, has a current P/E ratio of 4.54. This is significantly lower than the industry averages, indicating potential undervaluation.

The P/E ratio often reflects investor sentiment about a company's growth prospects. Given Nortech Systems' low P/E ratio compared to its peers, it raises the question of whether investors recognize its growth potential.

Is Nortech Systems a growth company? Its innovative advancements and recent strategic initiatives suggest it might be, though the market may not yet fully reflect this in its valuation.

The Team

NanoViricides, Inc. (NNVC) is a development-stage company focused on creating special-purpose nanomaterials for antivira...
05/21/2024

NanoViricides, Inc. (NNVC) is a development-stage company focused on creating special-purpose nanomaterials for antiviral therapy. Their innovative nanoviricide® drug candidates specifically target and dismantle enveloped virus particles, presenting a potential breakthrough in antiviral treatments.

Bio-Nano Technology - Full Breakout Analysis and Disclaimer:https://broadstreetalerts.com/wp-content/uploads/2024/05/BSA-NNVC-analysis-05-21-2024.pdf

Lead Drug Candidate: NV-387
NanoViricides' primary focus is on their lead drug candidate, NV-387, designed for the treatment of multiple respiratory viral infections, including RSV, COVID-19, Long COVID, and various strains of influenza. NV-387 has completed a Phase 1a/1b clinical trial with no reported adverse events, underscoring its safety profile.

Recent Developments and Catalysts
NNVC has recently announced several significant developments regarding NV-387, highlighting its potential as a broad-spectrum antiviral:

Completion of Phase 1a/1b Trial: NV-387 has successfully completed its Phase 1a/1b clinical trial, with data lock expected soon. The absence of adverse events during this trial is a promising indicator of the drug's safety. The company is now in discussions for Phase II clinical protocols, targeting RSV infections in various age groups, including infants and children.

Broad-Spectrum Efficacy: NV-387 has demonstrated extensive antiviral activity in animal models, proving effective against:

Coronavirus
Respiratory Syncytial Virus (RSV)
Influenza A, including potential efficacy against Bird Flu H5N1
Smallpox and Mpox (Orthopoxviruses)
Notably, NV-387 showed superior performance compared to existing antiviral drugs in lethal animal models, suggesting it could serve as a universal treatment for numerous respiratory infections.

Regulatory Pathways: NNVC plans to submit a pre-IND application to the US FDA for NV-387, seeking guidance to refine their Phase II clinical trial design. The goal is to initially test the drug in adults and, if successful, expand trials to include hospitalized infants and children.

Additional Drug Candidates
In addition to NV-387, NNVC is advancing NV-HHV-1 for treating shingles rash, HSV-1 "cold sores", and HSV-2 "ge***al ulcers." Other targets in their pipeline include drugs for viral diseases such as:

Oral and ge***al herpes
Eye infections (EKC and herpes keratitis)
Influenza strains (H1N1 and H5N1)
HIV, Hepatitis C, Rabies, Dengue fever, and Ebola virus

Platform Technology
NanoViricides' drug candidates leverage TheraCour® nanomedicine technology, licensed from AllExcel. This platform allows the development of drugs with specific targeting mechanisms against a variety of human viral diseases, offering NNVC exclusive and perpetual rights to this technology for numerous viruses.

Breakout Alert: Ensysce Biosciences, Inc. (NASDAQ: ENSC)Multiple potential near-term catalysts. See the full analysis be...
05/15/2024

Breakout Alert: Ensysce Biosciences, Inc. (NASDAQ: ENSC)

Multiple potential near-term catalysts. See the full analysis below.

>>> Click here for the full ENSC analysis:https://broadstreetalerts.com/wp-content/uploads/2024/05/BSA-ENSC-Analysis-5-15-24.pdf

You have to see what they have in the pipeline that recently received Fast Track Designation.

The public float is around 7.5m
Current $0.555

Technical Analysis

Historical Volatility and Current Opportunity
ENSC is known for experiencing substantial volatility over short periods. Currently, it presents a unique opportunity as it has significantly deviated from its 50-day moving average, creating potential for upside.

Moving Average and RSI Indicators
ENSC’s 50-day moving average stands at 0.69, more than 25% above Tuesday's closing price. Additionally, the Relative Strength Index (RSI) is at 39, suggesting the stock may be poised for an upward move if it maintains levels above its recent lows.

A Digital Mining Laggard with Multiple Catalysts. Gryphon Digital Mining (NASDAQ: GRYP) potential near-term breakout.Ful...
05/08/2024

A Digital Mining Laggard with Multiple Catalysts.

Gryphon Digital Mining (NASDAQ: GRYP) potential near-term breakout.

Full analysis here:https://broadstreetalerts.com/wp-content/uploads/2024/05/GRYP-BSA-ANALYSIS.pdf

The leadership team at Gryphon brings significant experience from other major companies in the block-chain and digital mining industries, such as Riot Blockchain and Marathon Digital Holdings.

Highlights

Recently announced buyback program.

Gryphon's new T-21 mining machines are outperforming by 25% compared to S-21's.

Seeking Acquisitions.

100% Carbon-Neutral.

Currently producing $88k/day at an average Bit-coin price of $66.18K.

Cantor Fitzgerald issued a   Macro Update as "US Senate Passes the Prohibiting Russian Uranium Imports Act, Now Sent to ...
05/02/2024

Cantor Fitzgerald issued a Macro Update as "US Senate Passes the Prohibiting Russian Uranium Imports Act, Now Sent to Biden" (NASDAQ: UUUU) reporting after the bell Friday, May 3rd - analysis here>>> https://bestgrowthstocks.com/growth-stocks/potential-bounce-back-following-supply-chain-issues-and-a-shakeup-merger-in-the-uranium-sector/

$UEC $UROY $DNN $URG $EU $URNM $CCJ $URA

Full Uranium Analysis with Merger Details and More on (NASDAQ: UUUU) >>> https://bestgrowthstocks.com/growth-stocks/potential-bounce-back-following-supply-chain-issues-and-a-shakeup-merger-in-the-uranium-sector/

Comprehensive Analysis of the Triller (NASDAQ: AGBA) Merger
04/22/2024

Comprehensive Analysis of the Triller (NASDAQ: AGBA) Merger

NEW YORK, NY/ NewsDirect/ April 22nd, 2024/ Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of recent merger announcement...

$PARA (NASDAQ: PARA) Analysis covers Paramount Global’s buyout options, potential outcomes, current estimated valuation,...
04/22/2024

$PARA (NASDAQ: PARA) Analysis covers Paramount Global’s buyout options, potential outcomes, current estimated valuation, cash position, breakdown of recent developments, short interest, financial performance, and more. CLICK HERE>>> https://www.nasdaq.com/press-release/bestgrowthstocks.com-unveils-in-depth-review-of-paramount-globals-latest-merger-bid

NEW YORK, NY/ NewsDirect/ April 22nd, 2024/ Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks utilizing exclusive ai-assisted research recently issued a comprehensive evaluation of recent merger and buyout b...

Address

New York, NY

Alerts

Be the first to know and let us send you an email when Broad Street Alerts posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Broad Street Alerts:

Share

FEEL THE DIFFERENCE AT BROAD STREET!

"At Broad street alerts, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Broad street alerts comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities. Broad street alerts was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities."

_____________________________________________

Privacy Policy and Disclaimer

Your Consent

Nearby media companies


Other Media/News Companies in New York

Show All